First Impression: Sonic Healthcare-SHL- FY16 result

Bell Potter

Stockbroker

Net operating cash flow up 38% to $708m | Segment EBITA; Pathology up 27% to$625.1m; Radiology down 14% to $47.7m; IPN & Other $42.3m, up 4.x | Outlook: “Sonic expects EBITDA growth of approximately 5% for 2017 on a Constant Currency basis,, excluding potential upside from any future business acquisitions and Australian regulatory reform. The guidance allows for A$5M of new rent expense for the properties sold and leased back in 2016. Net interest expense is expected to increase by 5-10% from the 2016 level of A$63M on a Constant Currency basis (excluding future business acquisitions), mainly as a result of higher margins on CHF debt, which in 2016 was drawn from a low margin short term bridge facility. The effective tax rate is expected to be approximately 25%.”


1 stock mentioned

Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.